Delivery Order SPE2DB22D1106-SPE2DB25FDMH6
Award Date
11/20/24
Potential Completion Date
11/21/24
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,632.60 firm fixed price contract is for the delivery of 4,568,194,784 units of Remifentanil 2MG, a medication used for pain management. The award has an ultimate completion date of May 12, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Remifentanil 2 mg vials. The $4,848.64 firm-fixed-price contract has a completion date of September 15, 2021. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,852.40, is for the delivery of REMIFENTANIL 2 MG VIALS, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of May 13, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,755.60 firm fixed price delivery order is for the supply of 1 mg vials of the drug remifentanil. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical for delivering a comprehensive range of medical commodities to support military...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,489.05 contract is for the delivery of Remifentanil 5 mg vials, with a period of performance ending on June 30, 2025. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Remifentanil 1 mg vials, a prescription pain medication. The contract has a ceiling value of $4,925.60 and is a firm fixed price, non-set-aside contract with a performance period ending on June 24, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...
This federal contract award is for the delivery of 2 mg vials of the pharmaceutical drug remifentanil, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,782.48 firm fixed price delivery order contract is funded by the Defense Logistics Agency (DLA), a defense agency. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 2 mg vials of the medication Remifentanil, with a ceiling value of $1,676.23 and a period of performance through July 1, 2025. The contract is a firm fixed-price, non-set-aside award, meaning it was open to full and open competition. AmerisourceBergen Drug Corporation...
This is a $1,139.66 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency. The contract is for the supply of Remifentanil 1 mg vials, a pain medication, with a completion date of May 30, 2025. The contract is not set aside and allows for open competition. Amerisourcebergen Drug Corp is a significant supplier to the federal government, holding a $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award, with ID SPE2DX15D7067|SPE2DX24F2ZVJ, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,649.40 firm fixed-price delivery order is for the supply of 2 mg vials of the pharmaceutical product Remifentanil. The contract has a completion date of July 9, 2024 and does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00...